Document:

Exhibit 10.1

EXHIBIT 10.1

ADDENDUM

This Addendum ("Addendum"), to the Investment Agreement dated September 15, 2009 (the
"Investment Agreement") between Dutchess Opportunity Fund, II, LP f/k/a Dutchess Equity Fund, LP, ("Dutchess") and
MMR Information Systems, Inc., (the "Company"), and the Registration Rights Agreement dated September 15, 2009
between Dutchess and the Company ("Registration Rights Agreement") is made this 18th day of June,
2010.

WHEREAS, it is in the best interest of both parties to facilitate (the
"Facilitation") the amendments in connection with the Investment Agreement and Registration Rights
Agreement (collectively, hereinafter referred to as the "Equity Line Transaction Documents").

NOW, THEREFORE, in consideration of the premises and mutual covenants and
agreements set forth herein and in reliance upon the representations and warranties contained herein, the parties hereto
covenant and agree as follows:

	Amendment to the Investment Agreement.  

	The Investment Agreement is hereby amended to DELETE in its entirety the definition of
Purchase Price and contemporaneously the Investment Agreement is hereby amended to INSERT the following
sentence as the amended definition of Purchase Price:

"Purchase Price" shall mean ninety-four percent (94%) of the average of two lowest
daily VWAP during the Pricing Period. 

	The Investment Agreement is hereby amended to DELETE in its entirety the definition of
Best Bid.

	The Investment Agreement is hereby amended to DELETE in its entirety the definition of
VWAP and contemporaneously the Investment Agreement is hereby amended to INSERT the following sentence as the
amended definition of VWAP:

"VWAP" means the volume weighted average price of the Common Stock for such
date on the Principal Market on which the Common Stock is then listed or quoted for trading as reported by Bloomberg
Financial L.P. or other nationally recognized quotation service.

	The Investment Agreement is hereby amended to DELETE in its entirety section 2(c) of
the Investment Agreement and any reference to the Minimum Acceptable Price.

Any such reference made in the Investment Agreement to Purchase Price,
VWAP, Minimum Acceptable Price or Best Bid, shall refer to the amended sections, as
described herein.

	The first preamble to the Investment Agreement is hereby amended and restated in its
entirety to read as follows:

"WHEREAS, the parties desire that, upon the terms and subject to the conditions
contained herein, the Investor shall invest up to Ten Million dollars ($10,000,000) to purchase the Company's Common
Stock, $0.001 par value per share (the "Common Stock");" 

	Section 2(A) is hereby amended and restated in its entirety to read as follows:

"PURCHASE AND SALE OF COMMON STOCK. Subject to the terms and conditions set
forth herein, during the Open Period, the Company may issue and sell to the Investor, and the Investor shall purchase
from the Company, up to that number of Shares having an aggregate Purchase Price of Ten Million dollars
($10,000,000)."

	Section 9(I) is hereby amended and restated in its entirety to read as follows:

"when the Investor has purchased an aggregate of Ten Million dollars ($10,000,000) in the
Common Stock of the Company pursuant to this Agreement; or,"

	Amendment to the Registration Rights Agreement.  

	The Registration Rights Agreement is hereby amended to DELETE in its entirety the Section
2(b) and contemporaneously the Registration Rights Agreement is hereby amended to INSERT the following section as
the amended Section 2(b):

The Company shall use all commercially reasonable efforts to have the initial Registration
Statement declared effective by the SEC within one hundred eighty (180) calendar days after the Execution Date.

	No other terms, rights or provisions of the Equity Line Transaction Documents are or should
be considered to have been modified by the terms of this Addendum and each party retains all other rights, obligations,
privileges and duties contained in Equity Line Transaction Documents that correspond respectively to the Agreements.

Agreed and Accepted, and duly authorized to sign, on this 18th day of June, 2010 

By Dutchess:/s/ Douglas H. Leighton

                  
          Douglas H. Leighton, Managing Director

By Company:/s/ Robert H. Lorsch

                  
          Robert H. Lorsch, Chief Executive OfficerExhibit 10.2

EXHIBIT 10.2

EMPLOYMENT AGREEMENT

THIS EMPLOYMENT AGREEMENT (this "Agreement"), dated as of June 15, 2010 (the "Effective Date"), is made
by MyMedicalRecords, Inc., a Delaware corporation and MMRGlobal a Delaware Corporation ("the
Company") and Richard Teich (the "Executive").

WITNESSETH:

WHEREAS, the Company desires to employ the Executive as its Executive Vice President;

NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby
acknowledged, the parties hereby covenant and agree as follows:

	Employment

The Company hereby agrees to retain the Executive, and the Executive hereby agrees to be employed by the
Company, on an at-will basis and subject to the additional terms and conditions of this Agreement.

	Term

The term of this Agreement (the "Agreement Term") shall commence on the Effective Date and shall expire on
June 15, 2012 (the "Initial Term") unless extended or otherwise terminated pursuant to this Agreement (the
"Employment Period"). The Agreement Term shall be extended automatically for successive additional one-year periods
at the expiration of the then-current term unless written notice of non-extension is provided by the Company to the
Executive after appropriate Board resolution at least 60 days prior to the expiration of the Initial Term or such extended
term, as the case may be.

	Responsibilities

The Executive shall provide services as requested by the Company reporting to the Chief Executive Officer
("CEO") unless otherwise directed by the CEO. The Executive's job description and title(s) may be changed
the Company. The Executive agrees to devote all time, efforts and skills reasonably necessary to the performance of his
duties and responsibilities under this Agreement.

	Compensation

In consideration of the services rendered by the Executive during the term hereof the Company shall pay
Executive the amounts set forth below.

	Salary.   The Company shall pay the Executive, on a semi-monthly basis, a base salary of
$15,000 per month (the "Base Salary. The Base Salary shall be subject to a review after six months and then annual
reviews, provided that as of each June 1 during the Agreement Term the amount of the Base Salary shall increase by
not less than 5% of the then current base salary.
	Bonus.   The Executive shall be paid a signing bonus of $3,000 upon signing of this Agreement.

	Executive Benefits.   The Executive shall also be entitled to (i) health insurance pursuant to the
plan made available generally to employees of the Company or reimbursement of one half of the Executive's monthly
COBRA payment; (ii) Four (4) weeks' vacation for each 12-month period during the Employment Period; (iii) reasonable
travel expenses incurred in connection with her responsibilities; and (iv) such other benefits and

perquisites that are generally made available to senior executives of the Company from time to time.  Executive further agrees to be bound
by the policies and procedures outlined in the Company's Employee Manual.

	Indemnification. The Executive shall be provided with any indemnification rights and indemnification
insurance coverage on the same basis as are provided to other senior executives of the Company.
	Reimbursement of Expenses.   The Company shall reimburse all reasonable business expenses
and disbursements incurred by the Executive in the performance of his duties under this Agreement.
	Deferred Compensation and Interest. The Company acknowledge that the Executive agrees that it could
be necessary to defer certain payments or benefits, and the Company does not intend that Executive relinquish, and
Executive does not hereby relinquish, any rights thereto.
	Termination.   In the event that this Agreement is terminated by the Company without Cause (as
such term is defined herein), the Company shall continue paying the monthly salary required under Section 4(a) hereof
for two (2) months, if such termination occurs within the first year of employment; for three (3) months, if such
termination occurs between the first year and the last day of the second year of employment; and for six (6) months, if
such termination occurs after the last day of the second year of employment.  If this Agreement is terminated by the
Company due to Executive's misconduct (including, but not limited to, any act of dishonesty, willful misconduct, fraud or
embezzlement) or should the Executive make or attempt to make any unauthorized use or disclosure of material
confidential information or trade secrets of the Company or any parent or subsidiary corporation (any of the foregoing, a
"Cause"), then the Company shall not be required to continue paying the monthly salary required under
Section 4(a) and the Company shall only be required to pay such salary as has been accrued to that date pursuant to
the existing agreement for payout of any deferred salaries.  For purposes of clarification, a change in title or diminution
of responsibilities, regardless of the level of materiality, shall not be considered a termination under the provisions of this
Agreement.

	Miscellaneous

	Successors and Assigns.   This Agreement shall be binding upon and shall inure to the
benefit of the Company and the Executive, and their successors and assignees.
	Entire Agreement.   This Agreement sets forth the entire agreement of the Executive and the
Company in respect of the subject matter contained herein and supersedes all prior agreements, memoranda of
understanding, promises, covenants, arrangements, communications, representations or warranties, whether oral or
written, by the parties hereto in respect of the subject matter contained herein. Any amendment or modification of this
Agreement shall not be binding unless in writing and signed by the Company and the Executive.
	Severability.   In the event that any provision of this Agreement is determined to be invalid or
unenforceable, the remaining terms and conditions of this Agreement shall be unaffected and shall remain in full force
and effect, and any such determination of invalidity or unenforceability shall not affect the validity or enforceability of any
other provision of this Agreement.

	Notices.   All notices which may be necessary or proper for the Company or the Executive to give
to the other shall be in writing and shall be delivered by hand or sent by registered or certified mail, return receipt
requested and actually received, or by air courier, and shall be deemed given when sent, to the respective persons at
the addresses set forth in Annex A (or such other address as any party may provide to the other parties after the date
hereof).
	Governing Law.   This Agreement shall be governed by and enforceable in accordance with the
laws of the State of California, without giving effect to the principles of conflict of laws thereof.
	Counterparts.   This Agreement may be signed in counterparts, each of which shall be an original,
with the same effect as if the signatures thereto and hereto were upon the same Instrument.
	No Rules of Construction.   No rules of construction are intended by the parties hereto and none
shall be employed or used in the interpretation of this Agreement. For all purposes, both parties hereto shall be deemed
joint authors hereof.

IN WITNESS WHEREOF, the parties have executed this Agreement effective as of the date first set forth above.

MyMedicalRecords, Inc.

By: /s/ Robert H. Lorsch

    Name: Robert H. Lorsch

        Title: Chief Executive Officer

Richard Teich

By: /s/ Richard Teich

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00175-of-00352.parquet"}]]